FFRangio System vs Vivid E80

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CathWorks (acquired by Medtronic)
VS
by GE HealthCare

AI Verdict

The CathWorks FFRangio System provides AI-driven functional assessment of coronary artery disease to guide percutaneous coronary intervention (PCI) using angiographic data. In contrast, GE HealthCare's Vivid E80 is an AI-powered ultrasound system focused on enhancing diagnostic precision and workflow efficiency in cardiovascular imaging. While both leverage AI within cardiology, they address distinct clinical needs: interventional guidance versus diagnostic imaging.

Choose FFRangio System if…

Choose the FFRangio System if your primary need is real-time, wire-free, and drug-free 3D fractional flow reserve (FFR) guidance during percutaneous coronary intervention (PCI) procedures. This tool is ideal for interventional cardiologists seeking to quickly optimize and confirm PCI decisions by assessing the functional significance of coronary artery disease and the impact of potential interventions without invasive pressure wires.

View FFRangio System →

Choose Vivid E80 if…

Choose the Vivid E80 if your focus is on advanced, AI-powered cardiovascular ultrasound imaging for comprehensive diagnostic assessment. This system is best suited for cardiologists and radiologists who require enhanced diagnostic precision and workflow efficiency for non-invasive evaluation of cardiac structure and function, including automated measurements for left ventricle dimensions, ejection fraction, and strain.

View Vivid E80 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FFRangio System Vivid E80
Pricing Contact vendor for pricing information. Quote-based
Deployment SaaS, on-prem, hybrid On-premise (medical device)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FFRangio System

Tool A (FFRangio System) explicitly highlights an 'Intuitive user interface' and 'Seamless integration with cath lab boom and PACS', directly addressing ease of use within its specific clinical workflow. While Tool B (Vivid E80) features AI-driven automation for various measurements, which contributes to efficiency, Tool A's description directly emphasizes the user experience of its interface and integration.

Clinical Value

FFRangio System

Tool A (FFRangio System) offers a significant clinical advancement by providing 'wire-free and drug-free 3D FFR guidance', eliminating the need for invasive pressure wires and associated drugs. This reduces patient risk and discomfort while providing crucial data for PCI decisions. Tool B (Vivid E80) enhances diagnostic precision in ultrasound, but Tool A's approach represents a more fundamental shift in a diagnostic paradigm.

Pricing & Value

Tie

Both Tool A (FFRangio System) and Tool B (Vivid E80) require direct contact for pricing information, with no transparent details provided in the structured facts or readily available online. Without specific pricing, it is impossible to conduct a head-to-head comparison of their value propositions.

Enterprise Readiness

Vivid E80

Tool B (Vivid E80) explicitly states 'has_baa: yes' and 'hipaa_compliant: yes' in the provided facts, which are critical for enterprise deployment in healthcare. Tool A (FFRangio System) indicates 'likely' for BAA and 'unknown' for HIPAA compliance, despite being ISO 27001 certified, making Tool B a more definitively enterprise-ready solution in terms of regulatory compliance.

Innovation

FFRangio System

Tool A (FFRangio System) presents a more disruptive innovation with its 'wire-free and drug-free 3D FFR guidance', fundamentally changing how FFR is performed by eliminating invasive components. While Tool B (Vivid E80) incorporates advanced AI for ultrasound measurements, Tool A's approach represents a greater paradigm shift in a key diagnostic procedure for coronary artery disease.

Support & Docs

Vivid E80

As a product of GE HealthCare, a large and established medical device manufacturer, Tool B (Vivid E80) benefits from a robust global support network and comprehensive documentation, including publicly available service and user manuals. While Tool A (FFRangio System) offers instructions for use, the extensive infrastructure of GE HealthCare suggests a more comprehensive and accessible support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FFRangio System Vivid E80
Name FFRangio System Vivid E80
Company CathWorks GE HealthCare
Core Function Delivers wire-free and drug-free 3D FFR guidance for optimizing PCI decisions in coronary artery disease. Advanced AI-powered ultrasound system for cardiovascular imaging, enhancing diagnostic precision and workflow efficiency.
Primary AI Application Aids in quick angiogram analysis for real-time FFRangio values and simulated pullback curves. AI Auto Measure 2D, Easy AutoEF, Easy AFI LV, AI Cardiac Auto Doppler, AI FlexiViews LAA.
Key Differentiator Eliminates the need for invasive pressure wires, drugs, or a guide catheter. Real-time image processing for automatic gain optimization (Auto Tissue) and semi-automatic Doppler spectrum measurement (Spectrum Recognition).

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and Vivid E80.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The FFRangio System provides wire-free and drug-free 3D FFR guidance to optimize PCI decisions for patients with coronary artery disease. In contrast, the Vivid E80 is an advanced AI-powered ultrasound system for comprehensive cardiovascular imaging, enhancing diagnostic precision and workflow efficiency.
The FFRangio System uses artificial intelligence to aid in quick angiogram analysis, providing real-time FFRangio values and insights for PCI planning. The Vivid E80 integrates AI features such as AI Auto Measure 2D, Easy AutoEF, and Easy AFI LV to automate and enhance various measurements for cardiovascular ultrasound imaging.
The FFRangio System is deployed on-premise and integrates seamlessly with cath lab equipment and C-arm angiography systems, utilizing routine angiograms for its analysis. The Vivid E80 is also an on-premise medical device, functioning as an ultrasound system that supports DICOM connectivity for image processing and reporting.
The FFRangio System aims to minimize invasiveness by eliminating the need for invasive pressure wires, drugs, or a guide catheter for FFR measurements. The Vivid E80, as an ultrasound system, is inherently non-invasive, providing diagnostic imaging without requiring internal probes or medications.
The Vivid E80 is explicitly stated as HIPAA compliant and includes a Business Associate Agreement (BAA). The FFRangio System handles protected health information (PHI) and is ISO 27001 certified for information security, though its HIPAA compliance is unknown and a BAA is only stated as 'likely.'
The FFRangio System offers real-time FFRangio values at every point on the coronary tree, simulated pullback curves, a Lesion Impact feature, and an integrated sizing tool for non-invasive lesion measurements. The Vivid E80 provides AI-based measurements for left ventricle dimensions (AI Auto Measure 2D), ejection fraction (Easy AutoEF), global and segmental strain (Easy AFI LV), and AI Cardiac Auto Doppler.
AI Tool Finder
AI-powered search. Results may not be comprehensive.